Nakajima M - Search Results

1

Strategy Treatment of cT4b Esophageal Squamous Cell Carcinoma Using Docetaxel, Cisplatin, and 5-Fluorouracil.

Nakajima M, Muroi H, Kikuchi M, Kubo T, Takise S, Ihara K, Nakagawa M, Morita S, Nakamura T, Yamaguchi S, Kojima K. Nakajima M, et al. Anticancer Res. 2022 Jul;42(7):3725-3733. doi: 10.21873/anticanres.15862. Anticancer Res. 2022. PMID: 35790261

2

Significant correlation between expression of heat shock proteins 27, 70 and lymphocyte infiltration in esophageal squamous cell carcinoma.

Nakajima M, Kuwano H, Miyazaki T, Masuda N, Kato H. Nakajima M, et al. Cancer Lett. 2002 Apr 8;178(1):99-106. doi: 10.1016/s0304-3835(01)00825-4. Cancer Lett. 2002. PMID: 11849747

3

Glut-1 glucose transporter expression in esophageal squamous cell carcinoma is associated with tumor aggressiveness.

Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H. Kato H, et al. Among authors: nakajima m. Anticancer Res. 2002 Sep-Oct;22(5):2635-9. Anticancer Res. 2002. PMID: 12529975

4

Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H. Kato H, et al. Among authors: nakajima m. Anticancer Res. 2002 Nov-Dec;22(6C):3977-84. Anticancer Res. 2002. PMID: 12553021

5

Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma.

Kato H, Takita J, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Ojima H, Tsukada K, Kuwano H, Oriuchi N, Endo K. Kato H, et al. Among authors: nakajima m. Anticancer Res. 2003 Jul-Aug;23(4):3263-72. Anticancer Res. 2003. PMID: 12926062

6

Efficacy and toxicity of nedaplatin and 5-FU with radiation treatment for advanced esophageal carcinomas.

Kato H, Fukuchi M, Manda R, Nakajima M, Miyazaki T, Sohda M, Masuda N, Fukai Y, Tsukada K, Kuwano H. Kato H, et al. Among authors: nakajima m. Anticancer Res. 2003 Jul-Aug;23(4):3493-8. Anticancer Res. 2003. PMID: 12926096 Clinical Trial.

7

Inverse correlation between expression levels of p27 and the ubiquitin ligase subunit Skp2 in early esophageal squamous cell carcinoma.

Fukuchi M, Masuda N, Nakajima M, Fukai Y, Miyazaki T, Kato H, Kuwano H. Fukuchi M, et al. Among authors: nakajima m. Anticancer Res. 2004 Mar-Apr;24(2B):777-83. Anticancer Res. 2004. PMID: 15161026 Free article.

8

The role of insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in human esophageal cancer.

Sohda M, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Masuda N, Kuwano H. Sohda M, et al. Among authors: nakajima m. Anticancer Res. 2004 Sep-Oct;24(5A):3029-34. Anticancer Res. 2004. PMID: 15517912 Free article.

9

Prognostic value of the expression of Smad6 and Smad7, as inhibitory Smads of the TGF-beta superfamily, in esophageal squamous cell carcinoma.

Osawa H, Nakajima M, Kato H, Fukuchi M, Kuwano H. Osawa H, et al. Among authors: nakajima m. Anticancer Res. 2004 Nov-Dec;24(6):3703-9. Anticancer Res. 2004. PMID: 15736400 Free article.

10

The effectiveness of planned esophagectomy after neoadjuvant chemoradiotherapy for advanced esophageal carcinomas.

Kato H, Fukuchi M, Manda R, Faried A, Takita J, Nakajima M, Miyazaki T, Sohda M, Fukai Y, Masuda N, Tsukada K, Kuwano H. Kato H, et al. Among authors: nakajima m. Anticancer Res. 2004 Nov-Dec;24(6):4091-6. Anticancer Res. 2004. PMID: 15736457 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,755 results

Search Page

Filters